{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:46:52Z","timestamp":1793303212491,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jogc.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Obstetrics and Gynaecology Canada"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jogc.2024.102449","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T12:56:13Z","timestamp":1711630573000},"page":"102449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Guideline No. 448: Prevention of Rh D Alloimmunization"],"prefix":"10.1016","volume":"46","author":[{"given":"Karen","family":"Fung-Kee-Fung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candyce","family":"Hamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwen","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jogc.2024.102449_bib1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0887-7963(87)70010-8","article-title":"Failures of intravenous Rh immune globulin prophylaxis: an analysis of the reasons for such failures","volume":"1","author":"Bowman","year":"1987","journal-title":"Transfus Med Rev"},{"issue":"Suppl 1","key":"10.1016\/j.jogc.2024.102449_bib2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/pr.2013.208","article-title":"Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels","volume":"74","author":"Bhutani","year":"2013","journal-title":"Pediatr Res"},{"issue":"1","key":"10.1016\/j.jogc.2024.102449_bib3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jogc.2017.11.007","article-title":"Prevention of Rh Alloimmunization. SOGC Clinical Practice Guidelines. No. 133","volume":"40","author":"Fung Kee Fung","year":"2018","journal-title":"J\u00a0Obstet Gynaecol Can"},{"issue":"9","key":"10.1016\/j.jogc.2024.102449_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238844","article-title":"Antenatal and postpartum prevention of Rh alloimmunization: A\u00a0systematic review and GRADE analysis","volume":"15","author":"Hamel","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jogc.2024.102449_bib5","first-page":"CD000021","article-title":"Anti-D administration after childbirth for preventing Rhesus alloimmunisation","author":"Crowther","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jogc.2024.102449_bib6","article-title":"WinRHO SDF Product Monograph","year":"2022","journal-title":"Health Canada Drug Product Database"},{"issue":"1","key":"10.1016\/j.jogc.2024.102449_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2008.03735.x","article-title":"Lessons learnt from many years of experience using anti-D in humans for prevention of RhD immunization and haemolytic disease of the fetus and newborn","volume":"154","author":"Kumpel","year":"2008","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"10.1016\/j.jogc.2024.102449_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-018476","article-title":"Frequences and ethnic distribution of ABO and RhD blood groups in China: a population-based cross-sectional study","volume":"7","author":"Liu","year":"2017","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.jogc.2024.102449_bib9","first-page":"356","article-title":"Blood group distribution in basques","volume":"3","author":"Van der Heide","year":"1951","journal-title":"Am J Hum Genet"},{"issue":"9","key":"10.1016\/j.jogc.2024.102449_bib10","first-page":"871","article-title":"Compliance with postpartum Rh isoimmunization prophylaxis in Alberta","volume":"133","author":"Huchcroft","year":"1985","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.jogc.2024.102449_bib11","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0002-9378(16)34502-1","article-title":"Demonstration of Rh antigens in a 38-day-old fetus - ScienceDirect","volume":"99","author":"Bergstrom","year":"1967","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"3","key":"10.1016\/j.jogc.2024.102449_bib12","article-title":"Anti-D administration after spontaneous miscarriage for preventing Rhesus alloimmunisation","author":"Karanth","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.jogc.2024.102449_bib13","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/trf.12941","article-title":"It\u2019s time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group","volume":"55","author":"Sandler","year":"2015","journal-title":"Transfusion"},{"issue":"9","key":"10.1016\/j.jogc.2024.102449_bib15","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/jech.2005.036517","article-title":"Measuring paternal discrepancy and its public health consequences","volume":"59","author":"Bellis","year":"2005","journal-title":"J\u00a0Epidemiol Community Health"},{"issue":"8","key":"10.1016\/j.jogc.2024.102449_bib16","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/1471-0528.13801","article-title":"Cost-effectiveness of first trimester noninvasive fetal RhD screening for targeted antenatal anti-D prophylaxis in RhD-negative pregnant women: a model-based analysis","volume":"123","author":"Neovius","year":"2016","journal-title":"BJOG"},{"issue":"1","key":"10.1016\/j.jogc.2024.102449_bib17","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/s12884-018-2114-5","article-title":"Effectiveness and costs of non-invasive foetal RHD genotyping in rhesus-D negative mothers: a French multicentric two-arm study of 850 women","volume":"18","author":"Darlington","year":"2018","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.jogc.2024.102449_bib18","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1136\/bmj.39518.463206.25","article-title":"Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study","volume":"336","author":"Finning","year":"2008","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.jogc.2024.102449_bib19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/pd.5415","article-title":"Cell free fetal DNA to triage antenatal rhesus immune globulin: is it really cost-effective in the United States?","volume":"39","author":"Moise","year":"2019","journal-title":"Prenatal Diagnosis"},{"issue":"8","key":"10.1016\/j.jogc.2024.102449_bib20","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S1701-2163(15)30864-1","article-title":"Cost-effectiveness of the management of Rh negative pregnant women","volume":"35","author":"Duplantie","year":"2013","journal-title":"J\u00a0Obstet Gynaecol Can"},{"issue":"1","key":"10.1016\/j.jogc.2024.102449_bib21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/uog.14723","article-title":"Costs and benefits of non-invasive fetal RhD determination","volume":"45","author":"Teitelbaum","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.jogc.2024.102449_bib22","doi-asserted-by":"crossref","first-page":"138","DOI":"10.21307\/immunohematology-2019-681","article-title":"Detection of anti-D following antepartum injections of Rh immune globulin","volume":"14","author":"Kennedy","year":"1998","journal-title":"Immunohematology"},{"issue":"1","key":"10.1016\/j.jogc.2024.102449_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/vox.12302","article-title":"Interpretation of pretransfusion testing in obstetrical patients who have received antepartum Rh immunoglobulin prophylaxis","volume":"110","author":"Szkotak","year":"2016","journal-title":"Vox Sang"},{"issue":"3","key":"10.1016\/j.jogc.2024.102449_bib24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1537-2995.1993.33393174447.x","article-title":"A\u00a0retrospective study to determine the risk of red cell alloimmunization and transfusion during pregnancy","volume":"33","author":"Heddle","year":"1993","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.jogc.2024.102449_bib25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1537-2995.1968.tb04895.x","article-title":"Results of clinical trials of RhoGAM in women","volume":"8","author":"Pollack","year":"1968","journal-title":"Transfusion"},{"issue":"5641","key":"10.1016\/j.jogc.2024.102449_bib26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1136\/bmj.1.5641.399","article-title":"Incidence of maternal Rh immunization by ABO compatible and incompatible pregnancies","volume":"1","author":"Ascari","year":"1969","journal-title":"Br Med J"},{"issue":"10","key":"10.1016\/j.jogc.2024.102449_bib27","doi-asserted-by":"crossref","DOI":"10.3310\/hta13100","article-title":"Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation","volume":"13","author":"Pilgrim","year":"2009","journal-title":"Health Technol Assess"},{"issue":"1","key":"10.1016\/j.jogc.2024.102449_bib29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/tme.12091","article-title":"BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn","volume":"24","author":"Qureshi","year":"2014","journal-title":"Transfus Med"},{"issue":"2","key":"10.1016\/j.jogc.2024.102449_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030711","article-title":"Routine antenatal anti-D prophylaxis in women who are Rh(D) negative: meta-analyses adjusted for differences in study design and quality","volume":"7","author":"Turner","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jogc.2024.102449_bib31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.5694\/mja2.50266","article-title":"Single dose v two-dose antenatal anti-D prophylaxis: a randomised controlled trial","volume":"211","author":"White","year":"2019","journal-title":"The Medical Journal of Australia"},{"issue":"4","key":"10.1016\/j.jogc.2024.102449_bib32","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/aogs.14328","article-title":"Following targeted routine antenatal anti-D prophylaxis, almost half of the pregnant women had undetectable anti-D prophylaxis at delivery","volume":"101","author":"Sorensen","year":"2022","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"10.1016\/j.jogc.2024.102449_bib33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4049\/jimmunol.87.2.189","article-title":"Experimental Isoimmunization to Hemoantigens in Man","volume":"87","author":"Stern","year":"1961","journal-title":"The Journal of Immunology"},{"issue":"21","key":"10.1016\/j.jogc.2024.102449_bib34","first-page":"1245","article-title":"The pathogenesis and prevention of Rh immunization","volume":"97","author":"Zipursky","year":"1967","journal-title":"Can Med Assoc J"},{"issue":"1","key":"10.1016\/j.jogc.2024.102449_bib35","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0002-9378(87)80344-7","article-title":"Measurement of human fetoplacental blood volume in erythroblastosis fetalis","volume":"157","author":"Nicolaides","year":"1987","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.jogc.2024.102449_bib36","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/AOG.0b013e3181da7929","article-title":"Fetomaternal hemorrhage","volume":"115","author":"Wylie","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.jogc.2024.102449_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.contraception.2020.02.011","article-title":"The concentration of fetal red blood cells in first-trimester pregnant women undergoing uterine aspiration is below the calculated threshold for Rh sensitization","volume":"102","author":"Horvath","year":"2020","journal-title":"Contraception"},{"issue":"12","key":"10.1016\/j.jogc.2024.102449_bib39","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1001\/jama.2023.16953","article-title":"Induced abortion and the risk of Rh Sensitization","volume":"330","author":"Horvath","year":"2023","journal-title":"JAMA"},{"issue":"7704","key":"10.1016\/j.jogc.2024.102449_bib40","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(71)91493-0","article-title":"Role of induced abortion in rhesus immunization","volume":"1","author":"Queenan","year":"1971","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jogc.2024.102449_bib41","first-page":"37","article-title":"Rhesus sensitization in abortion","volume":"39","author":"Gavin","year":"1972","journal-title":"Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.jogc.2024.102449_bib42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0002-9378(72)90765-X","article-title":"Do RhD-negative women with an early spontaneous abortion need Rh immune prophylaxis?","volume":"113","author":"Visscher","year":"1972","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.jogc.2024.102449_bib43","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00006250-197803000-00013","article-title":"Reduced dose of Rh immunoglobulin following first trimester pregnancy termination","volume":"51","author":"Stewart","year":"1978","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jogc.2024.102449_bib44","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/bmjsrh-2021-201225","article-title":"Rhesus isoimmunization in unsensitized RhD-negative individuals seeking abortion at less than 12 weeks\u2019 gestation: a systematic review","volume":"48","author":"Chan","year":"2022","journal-title":"BMJ Sex Reprod Health"},{"issue":"3","key":"10.1016\/j.jogc.2024.102449_bib45","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/ajcp\/110.3.281","article-title":"Use of Rh immune globulin: ASCP practice parameter. American Society of Clinical Pathologists","volume":"110","author":"Hartwell","year":"1998","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.jogc.2024.102449_bib46","first-page":"749","article-title":"Transplacental fetal hemorrhage after amniocentesis","volume":"66","author":"Bowman","year":"1985","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.jogc.2024.102449_bib47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/oxfordjournals.humrep.a136340","article-title":"Feto-maternal transfusion after chorionic villus sampling: clinical implications","volume":"1","author":"Brambati","year":"1986","journal-title":"Hum Reprod"},{"issue":"5","key":"10.1016\/j.jogc.2024.102449_bib48","first-page":"839","article-title":"Fetomaternal hemorrhage following funipuncture: increase in severity of maternal red-cell alloimmunization","volume":"84","author":"Bowman","year":"1994","journal-title":"Obstet Gynecol"},{"issue":"Suppl 2","key":"10.1016\/j.jogc.2024.102449_bib49","first-page":"1","article-title":"An assessment of the hazards of amniocentesis. Report to the Medical Research Council by their Working Party on Amniocentesis","volume":"85","year":"1978","journal-title":"Br J Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.jogc.2024.102449_bib50","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1479-828X.1995.tb01862.x","article-title":"Fetomaternal haemorrhage after external cephalic version at term","volume":"35","author":"Lau","year":"1995","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"2","key":"10.1016\/j.jogc.2024.102449_bib37","article-title":"Practice Bulletin No. 181: Prevention of Rh D Alloimmunization","volume":"130","year":"2017","journal-title":"Obstetrics & Gynecology"},{"issue":"6","key":"10.1016\/j.jogc.2024.102449_bib51","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/tme.12380","article-title":"SHOT conference report 2016: serious hazards of transfusion - human factors continue to cause most transfusion-related incidents","volume":"26","author":"Bolton-Maggs","year":"2016","journal-title":"Transfus Med"},{"issue":"5","key":"10.1016\/j.jogc.2024.102449_bib52","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1701-2163(16)35239-2","article-title":"Anti-D in Rh(D)-negative pregnant women: are at-risk pregnancies and deliveries receiving appropriate prophylaxis?","volume":"34","author":"Koby","year":"2012","journal-title":"J\u00a0Obstet Gynaecol Can"},{"issue":"6","key":"10.1016\/j.jogc.2024.102449_bib53","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/01443610701469941","article-title":"The safety of RhIG in the prevention of haemolytic disease of the newborn","volume":"27","author":"Hirose","year":"2007","journal-title":"J\u00a0Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.jogc.2024.102449_bib54","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2337\/dc09-1822","article-title":"Review of adverse events associated with false glucose readings measured by GDH-PQQ-based glucose test strips in the presence of interfering sugars","volume":"33","author":"Frias","year":"2010","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.jogc.2024.102449_bib55","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1111\/all.12494","article-title":"Management of hypersensitivity reactions to anti-D immunoglobulin preparations","volume":"69","author":"Rutkowski","year":"2014","journal-title":"Allergy"},{"issue":"12","key":"10.1016\/j.jogc.2024.102449_bib56","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/jp.2014.134","article-title":"Maternal anti-D prophylaxis during pregnancy and risk of hemolysis among preterm infants","volume":"34","author":"Maayan-Metzger","year":"2014","journal-title":"J\u00a0Perinatol"}],"container-title":["Journal of Obstetrics and Gynaecology Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216324002603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1701216324002603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:43:30Z","timestamp":1761666210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1701216324002603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1701216324002603"],"URL":"https:\/\/doi.org\/10.1016\/j.jogc.2024.102449","relation":{},"ISSN":["1701-2163"],"issn-type":[{"value":"1701-2163","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guideline No. 448: Prevention of Rh D Alloimmunization","name":"articletitle","label":"Article Title"},{"value":"Journal of Obstetrics and Gynaecology Canada","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jogc.2024.102449","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Society of Obstetricians and Gynaecologists of Canada\/La Soci\u00e9t\u00e9 des obst\u00e9triciens et gyn\u00e9cologues du Canada. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102449"}}